Diagnostics & Research
The Diagnostics & Research industry has a total of 46 stocks, with a combined market cap of $863.42 billion, total revenue of $173 billion and a weighted average PE ratio of 48.12.
Market Cap
863.42B
Revenue
173B
Profits
17.94B
PE Ratio
48.12
Profit Margin
10.37%
Dividend Yield
0.20%
46 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 232.67B | 0.27% | 1,555,934 | 46.34B |
| 2 | DHR | Danaher Corporation | 153.85B | 1.36% | 4,701,658 | 25.11B |
| 3 | NTRA | Natera, Inc. | 47.86B | 2.21% | 1,214,609 | 2.71B |
| 4 | A | Agilent Technologies, Inc. | 44.91B | 1.73% | 2,730,100 | 7.23B |
| 5 | IDXX | IDEXX Laboratories, Inc. | 43.88B | 2.03% | 485,741 | 4.55B |
| 6 | IQV | IQVIA Holdings Inc. | 42.77B | 1.47% | 1,307,264 | 16.98B |
| 7 | WAT | Waters Corporation | 40.35B | 1.49% | 816,908 | 4.64B |
| 8 | ILMN | Illumina, Inc. | 33.13B | 2.89% | 1,916,821 | 4.49B |
| 9 | MTD | Mettler-Toledo International Inc. | 27.96B | 0.14% | 365,396 | 4.13B |
| 10 | LH | Labcorp Holdings Inc. | 27.28B | 1.06% | 792,639 | 14.35B |
| 11 | DGX | Quest Diagnostics Incorporated | 26.97B | 1.28% | 1,263,051 | 11.56B |
| 12 | GH | Guardant Health, Inc. | 22.91B | 1.67% | 1,907,789 | 1.18B |
| 13 | MEDP | Medpace Holdings, Inc. | 17.33B | 1.32% | 225,438 | 2.78B |
| 14 | CRL | Charles River Laboratories International, Inc. | 14.09B | 1.28% | 887,531 | 4.00B |
| 15 | RVTY | Revvity, Inc. | 13.92B | 0.50% | 2,289,714 | 2.91B |
| 16 | ICLR | ICON Public Limited Company | 13.29B | -1.17% | 391,169 | 8.29B |
| 17 | TWST | Twist Bioscience Corporation | 9.13B | 6.79% | 1,792,958 | 431.80M |
| 18 | QGEN | Qiagen N.V. | 9.11B | -1.85% | 3,304,170 | 2.10B |
| 19 | RDNT | RadNet, Inc. | 6.05B | -0.30% | 644,046 | 2.27B |
| 20 | SHC | Sotera Health Company | 5.58B | 1.82% | 2,350,203 | 1.22B |
| 21 | BLLN | BillionToOne, Inc. | 4.48B | -0.25% | 588,370 | 397.41M |
| 22 | ADPT | Adaptive Biotechnologies Corporation | 4.15B | 2.16% | 1,815,950 | 308.08M |
| 23 | GRAL | GRAIL, Inc. | 3.55B | 2.01% | 603,902 | 165.26M |
| 24 | VCYT | Veracyte, Inc. | 3.40B | 1.24% | 1,005,479 | 561.90M |
| 25 | WGS | GeneDx Holdings Corp. | 2.60B | 5.47% | 555,045 | 454.43M |
| 26 | CDNA | CareDx, Inc. | 2.51B | 3.45% | 1,159,500 | 458.09M |
| 27 | NEO | NeoGenomics, Inc. | 2.18B | 2.72% | 1,139,749 | 766.30M |
| 28 | PSNL | Personalis, Inc. | 1.96B | 8.89% | 7,761,599 | 69.67M |
| 29 | FRNM | Freenome, Inc. | 1.56B | 2.22% | 735,008 | 34.24M |
| 30 | OPK | OPKO Health, Inc. | 1.10B | 1.37% | 2,402,146 | 587.90M |
| 31 | CSTL | Castle Biosciences, Inc. | 1.04B | 3.86% | 573,436 | 357.28M |
| 32 | FLGT | Fulgent Genetics, Inc. | 547.55M | -0.10% | 323,956 | 323.93M |
| 33 | MYGN | Myriad Genetics, Inc. | 306.08M | -0.62% | 1,279,033 | 806.60M |
| 34 | BDSX | Biodesix, Inc. | 280.98M | 10.82% | 272,559 | 102.94M |
| 35 | XGN | Exagen Inc. | 191.86M | 1.80% | 251,689 | 71.12M |
| 36 | IMDX | Insight Molecular Diagnostics Inc. | 142.02M | 0.93% | 38,690 | 1.67M |
| 37 | QUCY | Quantum Cyber N.V. | 109.29M | -4.41% | 1,036,326 | 537.08K |
| 38 | BNR | Burning Rock Biotech Limited | 103.14M | 5.73% | 4,629 | 74.58M |
| 39 | MDXH | MDxHealth SA | 70.90M | 3.21% | 391,422 | 114.02M |
| 40 | PRPO | Precipio, Inc. | 54.43M | 3.47% | 69,643 | 27.20M |
| 41 | ADVB | Advanced Biomed Inc. | 13.45M | -0.61% | 77,674 | - |
| 42 | MBAI | Check-Cap Ltd. | 8.88M | 0.25% | 4,397 | - |
| 43 | XWEL | XWELL, Inc. | 8.78M | 11.82% | 108,407 | 28.28M |
| 44 | NDRA | ENDRA Life Sciences Inc. | 5.70M | -2.07% | 27,336 | - |
| 45 | ISPC | iSpecimen Inc. | 4.11M | -25.55% | 1,514,300 | 466.30K |
| 46 | BIAF | bioAffinity Technologies, Inc. | 3.24M | -0.02% | 1,000,748 | 5.90M |